Nuvisan
Contract research and development
- B2B
About Nuvisan
A European contract research and development organization with over 40 years of experience, offering integrated solutions in drug discovery, development, and manufacturing
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Neu-Ulm, Bavaria, Germany
- Founded
- 1989
- Revenue
- $20.9M – $165MTamtam estimate
- Website
- nuvisan.com
- linkedin.com/company/nuvisan
Nuvisan in the news
- NUVISAN receives US$9.6m grant for a multi-target drug discovery program on novel non-hormonal contraceptive medicines
NUVISAN has secured a $9.6 million grant to develop novel non-hormonal contraceptive medicines.
- NUVISAN und ALS Limited unterzeichnen strategische Partnerschaft zur Erschließung neuer Märkte
NUVISAN partners with ALS Limited to expand into new markets and enhance its life sciences capabilities.
- Bayer moves 400 R&D jobs to CRO-run small molecules unit
Bayer is outsourcing 400 R&D jobs to Nuvisan's new Berlin center to focus on small molecule drug discovery as part of a major restructuring.
- Lohnhersteller Nuvisan übernimmt Auftragslabor Inamed
Nuvisan has acquired Inamed to enhance its clinical research capabilities and access to specialized patient populations.
- THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
NUVISAN Group is growing by acquiring Galderma's R&D capabilities from Nestlé Skin Health.
Nuvisan at a glance
Nuvisan is a B2B company in the Biotechnology Research industry, headquartered in Neu-Ulm, Bavaria, Germany.
Nuvisan was founded in 1989.
Nuvisan has 251–1,000 employees.
Nuvisan's revenue is $20.9M – $165M (Tamtam estimate).
Selling to companies like Nuvisan?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies